Document Detail

Public health issues related to infection in pregnancy and cerebral palsy.
MedLine Citation:
PMID:  11921385     Owner:  NLM     Status:  MEDLINE    
Cerebral palsy is the most common neuromotor developmental disability of childhood, affecting as many as 8,000 to 12,000 children born in the U.S. each year (corresponding to a prevalence rate of between 2 and 3 per 1000 children). Recent improvements in neonatal care have not resulted in a decline in the overall prevalence of cerebral palsy and, in fact, greater numbers of very preterm/very low birth weight infants are surviving with cerebral palsy and other developmental problems. Infection in pregnancy may be an important cause of the disorder. In preterm infants, there appears to be about a 2-fold increased risk for cerebral palsy from chorioamnionitis, and in term infants the estimated increased risk is about 4-fold. Provisionally, chorioamnionitis might account for 12% of spastic cerebral palsy in term infants and 28% of cerebral palsy in preterm infants. Studies of biochemical markers of fetal inflammation typically associated with infection also suggest that an inflammatory response may be an important independent etiologic factor. If a substantial proportion of cerebral palsy is attributable to acute amnionitis infection and/or neonatal sepsis, cerebral palsy should have decreased in the United States after administration of intrapartum antibiotics became widespread in response to publication of public health consensus guidelines for Group B streptococcus in 1996. However, failure to detect declines could have a number of explanations and these explanations illustrate the many public health challenges related to intrauterine infection and cerebral palsy. Given the gaps in our current knowledge about intrauterine infection and cerebral palsy, public health recommendations for timely and specific prevention activities are limited at this time.
Diana E Schendel; Anne Schuchat; Poul Thorsen
Related Documents :
16765725 - Cerebral palsy and intrauterine growth.
10547255 - Cerebral vasoreactivity to arterial carbon dioxide tension in preterm infants: the effe...
17272615 - Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weig...
1600305 - Dyskinetic and dystonic cerebral palsy and birth.
1259235 - Miliary tuberculosis in two infants after nursery exposure: epidemiologic, clinical, an...
22813065 - Relationship between the neonatal white blood cell count and histologic chorioamnioniti...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Mental retardation and developmental disabilities research reviews     Volume:  8     ISSN:  1080-4013     ISO Abbreviation:  Ment Retard Dev Disabil Res Rev     Publication Date:  2002  
Date Detail:
Created Date:  2002-03-28     Completed Date:  2002-05-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9517974     Medline TA:  Ment Retard Dev Disabil Res Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  39-45     Citation Subset:  IM    
Copyright Information:
Copyright 2002 Wiley-Liss, Inc.
Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / therapeutic use
Cerebral Palsy / epidemiology*,  prevention & control
Child Health Services
Guidelines as Topic
Infant, Newborn
Pregnancy Complications, Infectious / epidemiology*,  prevention & control
Public Health Practice
United States / epidemiology
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults.
Next Document:  Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in ...